Quantcast

Latest Rhinology Stories

2010-11-25 00:00:46

Although most consumers turn to the same over-the-counter medicines for winter colds, Buster Brands is ensuring that a change is in the works. Launching its "Send Us Your Nasal Spray" campaign, Buster Brands will be giving a free bottle of Sinus Buster or Allergy Buster to consumers that send in their old nasal spray. Morristown, NJ (Vocus/PRWEB) November 23, 2010 When fall and winter colds arrive, many consumers turn to the same over-the-counter medicines that they've been using for years,...

2010-11-16 14:02:34

In a small, short-term study, a preservative-free, acidified nasal spray appears safe and well tolerated and maintained its sterility in an applicator used multiple times, according to a report in the November issue of Archives of Otolaryngology"“Head & Neck Surgery, one of the JAMA/Archives journals. "The health of a topical nasal spray user relies on the prevention of contamination of the solution," the authors write as background information in the article. "Pharmaceutical...

2010-11-16 13:01:20

A preservative-free alternative to standard nasal sprays "” which routinely use preservatives that can cause unwanted side effects, such as allergies or damage to the mucosal lining of the nose "” was found to be both safe and well-tolerated, in a short-term study from the Stanford University School of Medicine. The alternative acidified solution also maintained sterility in the applicator bottle without the use of the chemical preservatives, according to the study, which will be...

2010-11-08 16:00:00

European Phase 2 Clinical Trial Evaluating WF10 as a Treatment for Severe Allergic Rhinitis Meets its Primary Endpoint MISSISSAUGA, ON, Nov. 8 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies and on the development of its immune modulating drug candidate WF10, today announced that its European...

2010-11-01 08:00:00

PALO ALTO, Calif., Nov. 1, 2010 /PRNewswire/ -- Intersect ENT, a medical device company that has developed a bioabsorbable drug-eluting stent to treat patients with chronic sinusitis, announced today the closing of a $30 million round of financing. Intersect ENT intends to use the proceeds to commercialize its initial product as well as build a portfolio of products for conditions treated by Ear, Nose, & Throat (ENT) surgeons. Medtronic, the world leader in medical technology,...

2010-10-07 07:00:00

SAN DIEGO and SEATTLE, Oct. 7 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis. The results demonstrated that VTX-1463 significantly improved allergy symptoms based on Total Nasal Symptom...

2010-10-06 06:30:00

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced positive preliminary results from a Phase 1/2 clinical study of bepotastine besilate nasal spray conducted in Canada for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The findings demonstrated two of the three bepotastine besilate concentrations tested were effective in relieving patients' nasal...

2010-09-27 06:10:00

BOSTON, Sept. 27 /PRNewswire/ -- Acclarent, Inc., a leader in minimally-invasive sinus surgery, today announced the introduction of two new technologies designed to improve visualization during sinus surgery -- The Acclarent Cyclops(TM) Multi-Angle Endoscope and the Relieva Luma Sentry(TM) Sinus Illumination System. The Relieva Luma Sentry(TM) Sinus Illumination System builds upon Acclarent's 510k cleared Relieva Luma® Technology. The Acclarent Cyclops(TM) Multi-Angle...

2010-08-16 13:38:19

Georgetown researcher says advances go unnoticed because they are not reported in targeted publications Facial pain. Nasal congestion. Postnasal drip. Fatigue. These are hallmark signs of chronic sinusitis, a swelling of tissue in the nasal and sinus cavity. The illness strikes millions of Americans each year and is one of the top five reasons patients visit their primary care doctor. Treating sinusitis is difficult in part because it's often not known if the cause is viral or bacterial....

2010-07-28 09:45:00

HORSHAM, Pa., July 28 /PRNewswire/ -- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal Aerosol was similar to placebo. "The outcomes of the...


Latest Rhinology Reference Libraries

Politzerization
2012-12-31 12:28:34

In 1861 Adam Politzer of Vienna spent much time studying the air movement in the Eustachian tubes and the ear canal. He would measure the air movement by attaching a manometer, a very large gauge, to the ear canal and the pharynx. He developed an apparatus known as the Politzer bag in 1863 which is a less invasive way to clear the Eustachian tubes. Procedure Politzerization, also known as the Politzer maneuver, is a medical procedure which inserts air in the middle ear while the patient...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.